Fuan Pharmaceutical (Group) Co., Ltd., together with its subsidiaries, research and develops, produces, and sells chemical drugs in the People's Republic of China and internationally. It offers APIs; intermediates; and FDFs, such as anti-tumor, specialty drugs, antibiotics, as well as freeze-drying preparation for injection. The company was formerly known as Chongqing Fuan Pharmaceutical (Group) Co., Ltd. and changed its name to Fuan Pharmaceutical (Group) Co., Ltd. in August 2013. The company was founded in 2004 and is headquartered in Chongqing, the People's Republic of China.
Research context
Fuan Pharmaceutical (Group) Co., Ltd appears in PyInvesting’s Shenzhen Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- CNY
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 6 months ago
Fuan Pharmaceutical (Group) Co., Ltd is currently in a long term downtrend where the price is trading 9.1% below its 200 day moving average.
From a valuation standpoint, the stock is 78.2% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.1.
Fuan Pharmaceutical (Group) Co., Ltd's total revenue sank by 18.2% to $548M since the same quarter in the previous year.
Its net income has dropped by 79.4% to $14M since the same quarter in the previous year.
Finally, its free cash flow fell by 215.5% to $-28M since the same quarter in the previous year.
Based on the above factors, Fuan Pharmaceutical (Group) Co., Ltd gets an overall score of 1/5.